Drug Search Results
Using advanced filters...
Advanced Search [+]

Dyclonine

Alternative Names: dyclonine, dyclopro, dyclone
Clinical Status: Inactive
Latest Update: 2024-12-11
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Voltage-Gated Sodium Channel Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous,Topical

FDA Designation: *

Approval Status: Approved

Approved Countries: Canada | India | Peru | Taiwan | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

Recent News Events

Date

Type

Title